You are here

Europe

Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed

Investors Business Daily

Sat, 09/21/19 - 12:28 pm

Wave Life Sciences

Jazz Pharmaceuticals

Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo

Endpoints

Fri, 09/20/19 - 10:40 pm

Evidence underpinning approval of new cancer drugs raises questions

Medical Express

Wed, 09/18/19 - 07:08 pm

J&J gets Stelara okay in Europe for ulcerative colitis

Pharmaforum

Fri, 09/6/19 - 08:35 pm

Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie

Endpoints

Fri, 09/6/19 - 10:09 am

non-squamous cell non-small cell lung cancer

Keytruda combo cleared as first-line kidney cancer treatment in EU

Pharmaforum

Thu, 09/5/19 - 08:20 pm

ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe

Fierce Pharma

Mon, 09/2/19 - 12:17 pm

Bristol-Myers Squibb

European Society of Cardiology

EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer

Endpoints

Thu, 08/29/19 - 12:26 pm

triple negative breast cancer

Bristol-Myers, AbbVie's multiple myeloma drug wins second EU nod as part of triple regimen

Endpoints

Wed, 08/28/19 - 12:38 pm

Bristol-Myers Squibb

relapsed or refractory multiple myeloma

Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe

Pharmaforum

Wed, 08/21/19 - 10:37 am

EMA and FDA Historically Agree on Just About Every New Drug Approval, but is That Slowly Changing?

RAPS.org

Fri, 08/16/19 - 12:57 pm

Brexit's Disruptive Impact On U.K. And European Prescription Drug Market

Forbes

Thu, 08/15/19 - 11:27 pm

Janssen gets EC approval for two new indications of Imbruvica

Pharmaceutical Business Review

Wed, 08/14/19 - 10:17 am

Waldenström’s macroglobulinemia

chronic lymphocytic leukemia

Novartis’ Zolgensma Joins Growing List of Medicines to Lose Accelerated Assessment Status in EU

RAPS.org

Mon, 07/29/19 - 11:19 pm

AbbVie's psoriasis launch Skyrizi hitting stride ahead of FDA's decision on upadacitinib

Fierce Pharma

Fri, 07/26/19 - 12:07 pm

rheumatoid arthritis

European VC Firm Medicxi Closes $448 Million Fund

CP Wire

Mon, 07/22/19 - 09:58 am

venture capital

Here's Why Pacific Biosciences Is Tumbling Today

Motley Fool

Fri, 07/19/19 - 12:53 pm

Pacific Biosciences

Alexion’s Soliris follow-up Ultomiris snares EU approval

Pharmaforum

Sun, 07/7/19 - 11:13 am

Roche closes on EU approval for Tecentriq in breast cancer

Pharmaforum

Mon, 07/1/19 - 11:57 am

triple negative breast cancer

Amgen/UCB hit another Evenity hurdle, as European regulators fail to back the osteoporosis drug

Endpoints

Fri, 06/28/19 - 10:04 am

Pages